After biomedical research, Singapore is strengthening its medical devices industry? What is the trend and progress in this regard?
There has definitely been a shift in focus to medical devices and diagnostics in Singapore. Much of this is due to the presence of strong capabilities in electrical and precision engineering found in Singapore. It has established deep capabilities in both basic biomedical sciences research and translational and clinical research over the past 10 years. This has laid the foundation for the country to move into more multi-disciplinary, multi-agency research collaborations for greater economic and health impact. Already, greater interactions have been established amongst biomedical and physical scientists, clinicians and engineers to translate research findings into medically-relevant applications.

The short R&D time-frame of medical devices and diagnostic products make them more commercially attractive. There is, however, a considerable gap in understanding the regulatory pathways for medical devices and diagnostics development. BioSingapore will help to increase the awareness of these industry segments through seminars and workshops.

Now that you are handling two major roles simultaneously, how are you planning to balance the focus?
It is definitely a big responsibility to be leading BioSingapore and helping shape the biomedical industry in Singapore. This role complements my current position as the director of strategy for Asia at Quintiles, where I focus on growth opportunities in Asia, strategic alliances and government relations. My firm understanding of the biomedical industry in the region, regional industry associations and regional companies will help to raise the profile of Singaporean biomedical companies and increase regional collaboration.